DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹13,034 Cr | ₹9,588 Cr | ₹8,572 Cr | ₹9,766 Cr | ₹8,104 Cr |
What is the latest Total Current Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹13,034 Cr |
Mar2024 | ₹9,588 Cr |
Mar2023 | ₹8,572 Cr |
Mar2022 | ₹9,766 Cr |
Mar2021 | ₹8,104 Cr |
How is Total Current Liabilities of DR REDDYS LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹13,034 Cr | 35.94 | |
Mar2024 | ₹9,588 Cr | 11.85 | |
Mar2023 | ₹8,572 Cr | -12.22 | |
Mar2022 | ₹9,766 Cr | 20.51 | |
Mar2021 | ₹8,104 Cr | - |
Compare Total Current Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹101,307.9 Cr | -6% | -7.3% | -12% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
MANKIND PHARMA | ₹108,009.0 Cr | 1.6% | 8.4% | 31.6% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -6% |
-7.3% |
-12% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses